1. Home
  2. PRSU vs ABCL Comparison

PRSU vs ABCL Comparison

Compare PRSU & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$33.44

Market Cap

960.2M

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.20

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSU
ABCL
Founded
1926
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
960.2M
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRSU
ABCL
Price
$33.44
$4.20
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$31.67
$7.75
AVG Volume (30 Days)
263.8K
4.2M
Earning Date
11-05-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
902.95
N/A
EPS
10.75
N/A
Revenue
$441,143,000.00
$35,325,000.00
Revenue This Year
$26.24
$25.45
Revenue Next Year
$8.08
$10.07
P/E Ratio
$3.27
N/A
Revenue Growth
4.63
7.17
52 Week Low
$26.66
$1.89
52 Week High
$42.43
$6.52

Technical Indicators

Market Signals
Indicator
PRSU
ABCL
Relative Strength Index (RSI) 45.36 58.74
Support Level $33.00 $4.08
Resistance Level $34.49 $4.66
Average True Range (ATR) 0.95 0.26
MACD -0.04 0.09
Stochastic Oscillator 45.35 64.77

Price Performance

Historical Comparison
PRSU
ABCL

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: